Timothy D Eubank
Overview
Explore the profile of Timothy D Eubank including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
1051
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pratt H, Ma L, Dziadowicz S, Ott S, Whalley T, Szomolay B, et al.
Clin Transl Med
. 2024 Mar;
14(3):e1595.
PMID: 38426634
Background: A better understanding of the pancreatic ductal adenocarcinoma (PDAC) immune microenvironment is critical to developing new treatments and improving outcomes. Myeloid cells are of particular importance for PDAC progression;...
2.
Sudhakaran M, Navarrete T, Mejia-Guerra K, Mukundi E, Eubank T, Grotewold E, et al.
Cell Death Dis
. 2023 Dec;
14(12):824.
PMID: 38092740
Triple-negative breast cancer (TNBC) is characterized by its aggressiveness and resistance to cancer-specific transcriptome alterations. Alternative splicing (AS) is a major contributor to the diversification of cancer-specific transcriptomes. The TNBC...
3.
Shaw M, Poncelet M, Viswakarma N, Vallerini G, Hameed S, Gluth T, et al.
Mol Imaging Biol
. 2023 Nov;
26(3):542-552.
PMID: 37945971
Purpose: This study aimed to develop a biocompatible oximetric electron paramagnetic resonance (EPR) spin probe with reduced self-relaxation, and sensitivity to oxygen for a higher signal-to-noise ratio and longer relaxation...
4.
Mihalik N, Steinberger K, Stevens A, Bobko A, Hoblitzell E, Tseytlin O, et al.
J Immunol
. 2023 Sep;
211(10):1589-1604.
PMID: 37756529
GM-CSF has been employed as an adjuvant to cancer immunotherapy with mixed results based on dosage. We previously showed that GM-CSF regulated tumor angiogenesis by stimulating soluble vascular endothelial growth...
5.
Eubank T, Bobko A, Hoblitzell E, Gencheva M, Driesschaert B, Khramtsov V
Mol Imaging Biol
. 2023 Aug;
26(3):424-434.
PMID: 37610610
Purpose: Hypoxia and acidosis are recognized tumor microenvironment (TME) biomarkers of cancer progression. Alterations in cancer redox status and metabolism are also associated with elevated levels of intracellular glutathione (GSH)...
6.
Rentz L, Whetsell M, Clayton S, Mizener A, Holaskova I, Chapa M, et al.
Int J Mol Sci
. 2023 Jul;
24(14).
PMID: 37511427
Breast cancer incidence in men is statistically rare; however, given the lack of screening in males, more advanced stages at initial diagnosis result in lower 5-year survival rates for men...
7.
Rentz L, Whetsell M, Clayton S, Mizener A, Holaskova I, Chapa M, et al.
bioRxiv
. 2023 Jun;
PMID: 37362158
Breast cancer incidence in men is statistically rare; however, given the lack of screening in males, more advanced stages at initial diagnosis results in lower 5-year survival rates for men...
8.
Steinberger K, Eubank T
Oxygen (Basel)
. 2023 May;
3(1):45-76.
PMID: 37124241
Low tissue oxygenation, termed , is a characteristic of solid tumors with negative consequences. Tumor-associated macrophages (TAMs) accumulate in hypoxic tumor regions and correlate with worse outcomes in cancer patients...
9.
Gluth T, Poncelet M, Gencheva M, Hoblitzell E, Khramtsov V, Eubank T, et al.
Anal Chem
. 2022 Dec;
95(2):946-954.
PMID: 36537829
Hypoxia, acidosis, and elevated inorganic phosphate concentration are characteristics of the tumor microenvironment in solid tumors. There are a number of methods for measuring each parameter individually in vivo, but...
10.
Ye Q, Hickey J, Summers K, Falatovich B, Gencheva M, Eubank T, et al.
Int J Mol Sci
. 2022 Dec;
23(23).
PMID: 36499305
There are currently no effective biomarkers for prognosis and optimal treatment selection to improve non-small cell lung cancer (NSCLC) survival outcomes. This study further validated a seven-gene panel for diagnosis...